KIT and gastrointestinal stromal tumor: Benzamide 111 was found to have submicromolar activities against MOLM-13 cells (GI50 = 544 nM) and GIST-T1 (GI50 = 647 nM), but showed moderate inhibitory activity against c-KIT/FLT3.